Assessment and Modulation of Energy Balance in Cachectic Patients Using Adapted Physical Activity
Launched by UNIVERSITY OF RENNES 2 · Oct 15, 2024
Trial Information
Current as of July 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how physical activity can help patients who are experiencing cancer cachexia, a condition causing weight loss and muscle wasting due to cancer. The study aims to measure how much energy these patients burn at rest and during exercise, comparing it to predictions based on standard equations and to non-cachectic cancer patients. Researchers will also track any changes in physical activity levels and dietary habits over a week while participants engage in a structured exercise program.
To be eligible for this study, participants must be at least 18 years old, currently undergoing cancer treatment, and able to understand the study's goals. Those with severe fatigue, anemia, certain infections, or serious heart or lung issues, among other conditions, may not qualify. Participants can expect to measure their breathing and energy use during exercise using a simple device, keep a log of their daily activities and food intake, and wear a fitness tracker for a week. It’s important to note that joining this study is completely voluntary, and it will not interfere with ongoing cancer treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be at least 18 years old.
- • Have understood the objectives of the study.
- • Have read and signed the consent form.
- • Be affiliated with a social security system.
- • Currently undergoing cancer treatment.
- Exclusion Criteria:
- • Une fatigue extrême
- • Une anémie symptomatique (hémoglobine ≤ 8 g/dl)
- • Un syndrome infectieux sévère en cours d'évolution
- • Une décompensation de pathologie cardio-pulmonaire
- • La présence de lésions osseuses lytiques du rachis ou des os longs (la contre-indication concerne la mobilisation du membre atteint)
- • Une intolérance au port du masque de l'appareil K5 (Cosmed)
About University Of Rennes 2
The University of Rennes 2 is a prestigious academic institution located in Rennes, France, known for its commitment to advancing research and education in the fields of humanities, social sciences, and health. As a clinical trial sponsor, the university leverages its interdisciplinary expertise to foster innovative research initiatives aimed at improving health outcomes and enhancing patient care. With a strong emphasis on ethical standards and regulatory compliance, the University of Rennes 2 collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous clinical trials that contribute to the scientific community and inform evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rennes, Bretagne, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported